Seminar this Thursday: Personalized Medicine: Challenges for Patients and Providers

The Poynter Center Presents a Healthcare Ethics Seminar:

“Personalized Medicine: Challenges for Patients and Providers”

Kenneth Cornetta, M.D.

Thursday, March 27, 2014, 4:00-5:30 pm

The Poynter Center, 618 E. Third Street, Bloomington IN 47405

Free and open to the public

An RSVP to is appreciated

Personalized medicine is a term that seeks to describe improved medical care made possible by advances in genetics and stem cell biology. Knowledge gained from the human genome project is leading to greater diagnostic and prognostic accuracy, while advances in regenerative medicine holds promise for designer cellular therapy. Gene therapy combines both fields to increase the therapeutic options for patients with previously life-threatening diseases.

While personalized medicine is being implemented rapidly, the ethical and religious implications have not been fully explored. Furthermore, patient preferences are for a more holistic approach to care, rather than increased technology. This discussion will present examples of personalized medicine and highlight potential areas of conflict where additional study is warranted.

Dr. Kenneth Cornetta received a M.D. from Albany Medical College in 1982.  He is board certified in internal medicine and hematology and has served as an attending physician in the IU Bone Marrow Transplantation Program since 1991. In 2002 he became Chair of the Department of Medical and Molecular Genetics. His research seeks to develop viral vectors for use in early phase clinical gene therapy applications and his laboratory has produced clinical material for over 20 Phase I/II trials throughout the United States and abroad.  Professor Cornetta is a Past-President of the American Society of Gene and Cell Therapy. The intersection of gene therapy, genetic diagnostic advances, and clinical experience in caring for cancer patients led to a sabbatical with Professor Candy Brown in 2012 where the ethical and religious impact of personalized medicine was explored.